Conférences  >  Médecine & Soins de Santé  >  Cancérologie  >  Virtuel (en ligne)

Sélecionner un pays
1
EUSTM-2024 — 11th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care
06 sep 2024 - 08 sep 2024 • Online Congress, Virtuel (en ligne)
Organisateur:
European Society for Translational Medicine
Résumé:
The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 11th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care (EUSTM-2024) held in virtual format during 6-8 September, 2024. The Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care. EUSTM-2024 not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.
Contact:
Tél.: [+43 1 8923 562];     Email.: immuno-2024@eutranslationalmedicine.org
Sujets:
solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, vaccines biological research, diagnostics, biomarkers, clinical care, Immunology, MIcrobiology, life sciences, Molecular Biology, Cancer, Blood Cancers, Breast cancer, Lungs Cancer, Ovarian cancer, GIT cancer, Brain cancer, Genitourinary cancer, prostate cancer, bladder cancer,
Identifiant de l'évènement:
1619613
2
EACR Next Generation Cancer Therapies
24 sep 2024 - 25 sep 2024 • Online, Virtuel (en ligne)
Organisateur:
The European Association for Cancer Research (EACR)
Résumé:
This conference will explore a breadth of new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients. The target audience for this conference is: scientists in academia and industry who are interested in the most recent developments in cancer therapeutic discovery, including small molecule, degrader, peptide, and antibody technologies. The conference will include several novel antitumour approaches in early clinical development. Join us online on 24 and 25 September to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 29 July and register before 09 September to secure your place.
Contact:
Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org
Sujets:
cancer research, oncology, therapeutic targets, cancer drug discovery, drug discovery approaches, new technical approaches to cancer therapeutics, early clinical development, small molecule technology, phenotypic screens, covalent fragment screens, degrader technology, PROTAC, molecular glue, peptide technology, oral cyclic peptide inhibitors, antibody technology, antitumour approaches, antibody drug conjugates, targeting RAS, targeting mutant p53.
Identifiant de l'évènement:
1616891
3
EACR Cancer and Ageing
03 dec 2024 - 04 dec 2024 • Online, Virtuel (en ligne)
Organisateur:
The European Association for Cancer Research (EACR)
Résumé:
This conference aims to illuminate the intricate dynamics between ageing and cancer, fostering interdisciplinary dialogue among researchers and clinicians. By understanding the biological dimensions of cancer in ageing populations, we aspire to drive innovations in prevention, diagnosis, and treatment strategies. Ultimately, the conference seeks to catalyse collaborative efforts to confront the unique challenges posed by cancer in the ageing world, with the overarching goal of improving the quality of life and outcomes for elderly cancer patients. This conference is relevant for a diverse range of researchers, clinicians, and industry professionals. We look forward to being joined by: scientists and academics working in oncology, gerontology, genetics, and related disciplines; clinical oncologists, geriatricians, and other healthcare professionals who play a crucial role in diagnosing, treating, and supporting elderly patients with cancer; and representatives from pharmaceutical companies and biotechnology firms which develop innovative therapies and technologies to combat cancer in ageing populations. Join us online on 03 and 04 December to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 14 October and register before 11 November to secure your place.
Contact:
Conference Officer: Chris Iliffe;     Tél.: [N/A];     Email.: christopher.iliffe@eacr.org
Sujets:
cancer research, oncology, ageing, ageing hallmarks, senescence, immunosenescence, inflammaging, aged tumour microenvironment, cancer prevention, cancer diagnosis, cancer treatment, elderly patients, treatment advances
Identifiant de l'évènement:
1620089
Sujets apparentés:
4
EACR-AstraZeneca Circulating Nucleic Acids (cfDNA/ctDNA): In use, in view and on the horizon
28 jan 2025 - 29 jan 2025 • Online, Virtuel (en ligne)
Organisateur:
The European Association for Cancer Research (EACR), in conjunction withAstraZeneca
Contact:
Conference Officer: Hannah Barrs;     Email.: hannah.barrs@eacr.org
Sujets:
cancer research, oncology, circulating tumour DNA, cell-free DNA, liquid biopsy, early cancer detection, clinical trial design, breast cancer, lung cancer, colorectal cancer, bladder cancer, virtual cancer research conference
Identifiant de l'évènement:
1623228
Sujets apparentés:
5
EACR Systemic Consequences of Cancer: Cancer as a Whole-body Disease
25 fév 2025 - 26 fév 2025 • Online, Virtuel (en ligne)
Organisateur:
The European Association for Cancer Research (EACR)
Résumé:
This meeting will delve into the profound consequences cancer can have on the body’s usual functions, and the underlying mechanisms behind these systemic effects. The ultimate goal is to explore how we might manipulate these mechanisms to develop more effective cancer treatments and improve the quality of life of patients with advanced cancer. We’ll be covering a wide range of topics including alterations in peripheral tissue function and the metabolic and inflammatory changes they induce, immune system performance, and cancer cachexia. This conference will be relevant for anyone with an interest in cancer biology, inter-organ communication, the role of cytokines, chemokines, and hormones in cancer, as well as cancer-induced changes in behaviour and metabolism.

Join us online on 25 and 26 February to learn more about this fascinating topic! Submit your abstract before 13 January and register before 03 February to secure your place.

Contact:
Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org
Sujets:
cancer research, oncology, cancer biology, immunology, cancer cachexia, inter-organ communication, liver function, muscle function, adipose tissue function, tissue function, metabolic changes, inflammatory changes, tumour metastasis, novel therapeutic interventions, cytokines, chemokines, hormones, cancer metabolism
Identifiant de l'évènement:
1620044
Sujets apparentés:


Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Y'a pas de suivi | Y'a pas de pop-ups | Y'a pas d'animations
Dernière mise à jour: 9 juin 2024